The first patient to undergo a liver transplant at Tufts Medical Center in Boston’s revived program says he’s "feeling fantastic" and enjoying life’s possibilities.
/PRNewswire/ Mallinckrodt plc (NYSE American: MNK), a global specialty pharmaceutical company, today announced the presentation of results from two clinical.